MarketPeel
Insider Trading Intelligence
DD

David T. Doherty

SGRY
CHIEF FINANCIAL OFFICER · SURGERY PARTNERS, INC. · CIK 0001908911
FILING MIX · LIFETIME32%/68%
BUYS
11
SELLS
23
TOTAL VALUE
$10.10M
COMPANIES
1
ACTIVE SINCE
Feb 2022
HOLDINGS NOW
221,679
AVG SELL PX
$26.26
TRADE KIND
SHOWING 34 / 34
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
23 backtested trades · 8 horizons · 10 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by David T. Doherty, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d23+56.52%-1.01%+0.42%-1.42%-1.22%
14d23+52.17%-1.41%+0.46%-1.88%-0.64%
30d23+65.22%-2.41%+0.55%-2.96%-4.08%
60d23+65.22%-5.45%+0.08%-5.53%-3.31%
90d23+60.87%-5.54%+2.06%-7.85%-8.99%
180d23(2 pending)+52.38%-10.16%+7.97%-18.13%-18.51%
1y23(3 pending)+95.00%-18.66%+17.42%-36.09%-36.52%
2y23(5 pending)+94.44%-35.49%+40.14%-75.63%-77.10%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SGRY · 221,679 shares · as of Mar 16, 2026
057,637115,273172,910230,5462023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 11 buys / 23 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
8,867$12.50$110.8K221,679Mar 16, 2026Mar 16, 2026View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
14,574$13.84$201.7K88,803Mar 6, 2026Mar 9, 2026View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
54,545$14.11$769.6K200,045Mar 5, 2026Mar 9, 2026View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
56,697$14.11$800.0K145,500Mar 5, 2026Mar 9, 2026View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
30,501$14.11$430.4K230,546Mar 5, 2026Mar 9, 2026View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
47,491$23.39$1.11M103,377Aug 8, 2025Aug 8, 2025View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
6,733$24.02$161.7K150,868Mar 10, 2025Mar 13, 2025View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
15,126$23.80$360.0K157,601Mar 4, 2025Mar 6, 2025View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
33,613$23.80$800.0K142,475Mar 4, 2025Mar 6, 2025View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
13,641$25.61$349.3K108,862Feb 7, 2025Feb 10, 2025View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
26,784122,503Jan 31, 2025Feb 4, 2025View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
721$28.59$20.6K95,719Mar 14, 2024Mar 15, 2024View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
3,426$30.37$104.0K96,440Mar 4, 2024Mar 6, 2024View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
25,657$31.18$800.0K99,866Feb 28, 2024Mar 1, 2024View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
1,020$34.93$35.6K74,209Feb 12, 2024Feb 14, 2024View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
2,306$31.89$73.5K75,229Feb 2, 2024Feb 6, 2024View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
2,000$36.12$72.2K77,535Aug 30, 2023Sep 1, 2023View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
202$35.21$7.1K79,535Aug 29, 2023Sep 1, 2023View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
21$30.11$63279,737Mar 15, 2023Mar 15, 2023View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
2,669$31.11$83.0K79,758Mar 14, 2023Mar 15, 2023View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
682$29.86$20.4K82,427Mar 13, 2023Mar 15, 2023View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
20,000$33.98$679.6K83,109Mar 3, 2023Mar 6, 2023View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
21,302$32.86$700.0K72,677Mar 2, 2023Mar 6, 2023View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
30,432$32.86$1000.0K103,109Mar 2, 2023Mar 6, 2023View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
4,315$33.53$144.7K51,375Feb 27, 2023Mar 1, 2023View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
942$33.92$32.0K55,690Feb 13, 2023Feb 15, 2023View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
1,947$35.90$69.9K56,632Feb 2, 2023Feb 6, 2023View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
171$29.65$5.1K58,579Aug 30, 2022Aug 31, 2022View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
1,091$50.90$55.5K58,750Mar 16, 2022Mar 17, 2022View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
3,678$49.29$181.3K59,841Mar 15, 2022Mar 17, 2022View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
376$54.69$20.6K63,519Mar 11, 2022Mar 14, 2022View →
SGRY
SURGERY PARTNERS, INC.
SALE
Chief Financial Officer
2,221$50.48$112.1K59,435Feb 25, 2022Mar 2, 2022View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
4,460$42.04$187.5K63,895Feb 10, 2022Mar 2, 2022View →
SGRY
SURGERY PARTNERS, INC.
PURCHASEGRANT
Stock grant
13,392$44.80$600.0K61,656Feb 1, 2022Feb 3, 2022View →
Other insiders · SGRY
Loading peer insiders…
About this filer
CIK 0001908911
ROLE
Chief Financial Officer
PRIMARY
SGRY
COMPANIES
1
ACTIVE SINCE
Feb 2022
MARKETPEEL · /INSIDER/0001908911DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback